Carglumic acid is an orphan drug used for the treatment of hyperammonaemia in patients with N-acetylglutamate synthase deficiency. This rare genetic disorder results in elevated blood levels of ammonia, which can eventually cross the blood-brain barrier and cause neurologic problems, cerebral edema, coma, and death.

Senkyunolide I has neuroprotective effect, associated with its anti-oxidation and anti-apoptosis properties.

Hydroxyethyl cellulose is a nonionic water-soluble modified cellulose polymer used as a thickener in water-soluble cosmetics and personal care formulations.